Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis
- PMID: 24939573
- PMCID: PMC4061543
- DOI: 10.1038/srep05336
Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis
Abstract
Reactive oxygen species (ROS) have been implemented in the etiology of pulmonary fibrosis (PF) in systemic sclerosis. In the bleomycin model, we evaluated the role of acquired mutations in mitochondrial DNA (mtDNA) and respiratory chain defects as a trigger of ROS formation and fibrogenesis. Adult male Wistar rats received a single intratracheal instillation of bleomycin and their lungs were examined at different time points. Ashcroft scores, collagen and TGFβ1 levels documented a delayed onset of PF by day 14. In contrast, increased malon dialdehyde as a marker of ROS formation was detectable as early as 24 hours after bleomycin instillation and continued to increase. At day 7, lung tissue acquired significant amounts of mtDNA deletions, translating into a significant dysfunction of mtDNA-encoded, but not nucleus-encoded respiratory chain subunits. mtDNA deletions and markers of mtDNA-encoded respiratory chain dysfunction significantly correlated with pulmonary TGFβ1 concentrations and predicted PF in a multivariate model.
Figures



Similar articles
-
Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosis.Sci Rep. 2019 Apr 2;9(1):5500. doi: 10.1038/s41598-019-41933-4. Sci Rep. 2019. PMID: 30940853 Free PMC article.
-
Exosomal miRNA Let-7 from Menstrual Blood-Derived Endometrial Stem Cells Alleviates Pulmonary Fibrosis through Regulating Mitochondrial DNA Damage.Oxid Med Cell Longev. 2019 Dec 16;2019:4506303. doi: 10.1155/2019/4506303. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31949877 Free PMC article.
-
[Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Jul;27(7):725-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011. PMID: 21722520 Chinese.
-
The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis.Int J Mol Sci. 2015 Sep 7;16(9):21486-519. doi: 10.3390/ijms160921486. Int J Mol Sci. 2015. PMID: 26370974 Free PMC article. Review.
-
Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis.Eur J Pharmacol. 2021 Dec 5;912:174613. doi: 10.1016/j.ejphar.2021.174613. Epub 2021 Nov 3. Eur J Pharmacol. 2021. PMID: 34740581 Review.
Cited by
-
The pathophysiological role of mitochondrial oxidative stress in lung diseases.J Transl Med. 2017 Oct 13;15(1):207. doi: 10.1186/s12967-017-1306-5. J Transl Med. 2017. PMID: 29029603 Free PMC article. Review.
-
Decreased Complex I Activity in Blood lymphocytes Correlates with Idiopathic Pulmonary Fibrosis Severity.Biochem Genet. 2025 Mar 4. doi: 10.1007/s10528-025-11071-w. Online ahead of print. Biochem Genet. 2025. PMID: 40038177
-
Mapping and editing animal mitochondrial genomes: can we overcome the challenges?Philos Trans R Soc Lond B Biol Sci. 2020 Jan 20;375(1790):20190187. doi: 10.1098/rstb.2019.0187. Epub 2019 Dec 2. Philos Trans R Soc Lond B Biol Sci. 2020. PMID: 31787046 Free PMC article. Review.
-
Mitochondria in lung disease.J Clin Invest. 2016 Mar 1;126(3):809-20. doi: 10.1172/JCI81113. Epub 2016 Mar 1. J Clin Invest. 2016. PMID: 26928034 Free PMC article. Review.
-
Circulating Mitochondrial DNA as a Mechanism-based, Prognostic Biomarker for Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med. 2017 Dec 15;196(12):1502-1504. doi: 10.1164/rccm.201708-1593ED. Am J Respir Crit Care Med. 2017. PMID: 28813161 Free PMC article. No abstract available.
References
-
- Tyndall A. J. et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Annals of the Rheumatic Diseases 69, 1809–1815, 10.1136/ard.2009.114264 (2010). - PubMed
-
- Gross T. J. & Hunninghake G. W. Idiopathic pulmonary fibrosis. N Engl J Med 345, 517–525, 10.1056/NEJMra003200 (2001). - PubMed
-
- King T. E. Jr, Pardo A. & Selman M. Idiopathic pulmonary fibrosis. Lancet 378, 1949–1961, 10.1016/S0140-6736(11)60052-4 (2011). - PubMed
-
- Daniels C. E. et al. Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. Am J Respir Crit Care Med 181, 604–610, 10.1164/rccm.200906-0964OC (2010). - PubMed
-
- Tashkin D. P. et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354, 2655–2666, 10.1056/NEJMoa055120 (2006). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical